{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:12:35Z","timestamp":1789150355409,"version":"build-2803163510"},"reference-count":43,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2001,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Extended-spectrum \u03b2-lactamases (ESBLs) are enzymes found in gram-negative bacilli that mediate resistance to extended-spectrum cephalosporins and aztreonam. In 1999, the National Committee for Clinical Laboratory Standards (NCCLS) published methods for screening and confirming the presence of ESBLs in<jats:italic>Klebsiella pneumoniae, Klebsiella oxytoca<\/jats:italic>, and<jats:italic>Escherichia coli<\/jats:italic>. To evaluate the confirmation protocol, we tested 139 isolates of<jats:italic>K. pneumoniae<\/jats:italic>that were sent to Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology) from 19 hospitals in 11 U.S. states. Each isolate met the NCCLS screening criteria for potential ESBL producers (ceftazidime [CAZ] or cefotaxime [CTX] MICs were \u22652 \u03bcg\/ml for all isolates). Initially, 117 (84%) isolates demonstrated a clavulanic acid (CA) effect by disk diffusion (i.e., an increase in CAZ or CTX zone diameters of \u22655 mm in the presence of CA), and 114 (82%) demonstrated a CA effect by broth microdilution (reduction of CAZ or CTX MICs by \u22653 dilutions). For five isolates, a CA effect could not be determined initially by broth microdilution because of off-scale CAZ results. However, a CA effect was observed in two of these isolates by testing cefepime and cefepime plus CA. The cefoxitin MICs for 23 isolates that failed to show a CA effect by broth microdilution were \u226532 \u03bcg\/ml, suggesting either the presence of an AmpC-type \u03b2-lactamase or porin changes that could mask a CA effect. By isoelectric focusing (IEF), 7 of the 23 isolates contained a \u03b2-lactamase with a pI of \u22658.3 suggestive of an AmpC-type \u03b2-lactamase; 6 of the 7 isolates were shown by PCR to contain both<jats:italic>ampC<\/jats:italic>-type and<jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub>genes. The IEF profiles of the remaining 16 isolates showed a variety of \u03b2-lactamase bands, all of which had pIs of \u22647.5. All 16 isolates were negative by PCR with multiple primer sets for<jats:italic>ampC<\/jats:italic>-type,<jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub>, and<jats:italic>bla<\/jats:italic><jats:sub>CTX-M<\/jats:sub>genes. In summary, 83.5% of the<jats:italic>K. pneumoniae<\/jats:italic>isolates that were identified initially as presumptive ESBL producers were positive for a CA effect, while 5.0% contained \u03b2-lactamases that likely masked the CA effect. The remaining 11.5% of the isolates studied contained \u03b2-lactamases that did not demonstrate a CA effect. An algorithm based on phenotypic analyses is suggested for evaluation of such isolates.<\/jats:p>","DOI":"10.1128\/jcm.39.8.2864-2872.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:06:23Z","timestamp":1027764383000},"page":"2864-2872","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":137,"title":["Characterization of Clinical Isolates of<i>Klebsiella pneumoniae<\/i>from 19 Laboratories Using the National Committee for Clinical Laboratory Standards Extended-Spectrum \u03b2-Lactamase Detection Methods"],"prefix":"10.1128","volume":"39","author":[{"given":"Christine D.","family":"Steward","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kamile","family":"Rasheed","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah K.","family":"Hubert","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Rollins School of Public Health, Emory University, Atlanta, Georgia 30322,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Biddle","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti M.","family":"Raney","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Rollins School of Public Health, Emory University, Atlanta, Georgia 30322,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Anderson","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia P.","family":"Williams","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Rollins School of Public Health, Emory University, Atlanta, Georgia 30322,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley L.","family":"Brittain","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Rollins School of Public Health, Emory University, Atlanta, Georgia 30322,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Oliver","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Servicio de Microbiolog\u0131\u0301a, Hospital Ramo\u0301n y Cajal, 28034 Madrid, Spain3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John E.","family":"McGowan","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Rollins School of Public Health, Emory University, Atlanta, Georgia 30322,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred C.","family":"Tenover","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.211"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1636"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.509"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.2741\/A477"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.9.2549-2553.2000"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.5.1110"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/24.1.82"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.4.447"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.5.1791-1796.2000"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(85)80989-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.2.207"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.2.358-363.1996"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/520193"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj2500753"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960000386"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.1.134"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.8.4897"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70249-X"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1986.tb09601.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.557"},{"key":"e_1_3_2_23_2","unstructured":"Mabilat C. Goussard S. PCR detection and identification of genes for extended-spectrum \u03b2-lactamases Diagnostic molecular microbiology: principles and applications. Persing D. H. Smith T. F. Tenover F. C. White T. J. 1993 553 559 American Society for Microbiology Washington D.C."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.342"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1669"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-88-1-169"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/1381612805666230112185101","article-title":"OXA-type \u03b2-lactamases","volume":"5","author":"Naas T.","year":"1999","unstructured":"Naas T. Nordmann P. OXA-type \u03b2-lactamases.Curr. Pharm. Des.51999865879","journal-title":"Curr. Pharm. Des."},{"key":"e_1_3_2_28_2","unstructured":"National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 4th ed. Approved standard M7\u2013A4. 1997 National Committee for Clinical Laboratory Standards Wayne Pa"},{"key":"e_1_3_2_29_2","unstructured":"National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing. Ninth information supplement M100\u2013S9. 1999 National Committee for Clinical Laboratory Standards Wayne Pa"},{"key":"e_1_3_2_30_2","unstructured":"National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 5th ed. Approved standard M7\u2013A5. 2000 National Committee for Clinical Laboratory Standards Wayne Pa"},{"key":"e_1_3_2_31_2","unstructured":"National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests 7th ed. Approved standard M2\u2013A7. 2000 National Committee for Clinical Laboratory Standards Wayne Pa"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/514905"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.5.943"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.616-620.2001"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.21.7378"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.10.2188"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.447-453.2001"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.838"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.3.647"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.2.362-367.2000"},{"key":"e_1_3_2_41_2","first-page":"57","article-title":"In vitro activity of fourth generation cephalosporins against Enterobacteriaceae producing extended-spectrum \u03b2-lactamases","volume":"8","author":"Sanders C. C.","year":"1996","unstructured":"Sanders C. C. In vitro activity of fourth generation cephalosporins against Enterobacteriaceae producing extended-spectrum \u03b2-lactamases.J. Chemother.8 (Suppl. 2)19965762","journal-title":"J. Chemother."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.33.9.2233-2239.1995"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(99)00165-X"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.4.525"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.8.2864-2872.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.39.8.2864-2872.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:47:41Z","timestamp":1682264861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.39.8.2864-2872.2001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["10.1128\/JCM.39.8.2864-2872.2001"],"URL":"https:\/\/doi.org\/10.1128\/jcm.39.8.2864-2872.2001","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"2000-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}